Growth Metrics

Merck (MRK) Shareholder's Equity (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -12.88%
Dec 31, 2025 1.57%
Sep 30, 2025 5.69%
Jun 30, 2025 1.36%
Mar 31, 2025 4.37%
Dec 31, 2024 4.07%
Sep 30, 2024 2.09%
Jun 30, 2024 7.98%
Mar 31, 2024 7.41%
Dec 31, 2023 -8.87%
Sep 30, 2023 6.60%
Jun 30, 2023 -17.40%
Mar 31, 2023 1.84%
Dec 31, 2022 3.45%
Sep 30, 2022 2.78%
Jun 30, 2022 5.77%
Mar 31, 2022 7.05%
Dec 31, 2021 6.68%
Sep 30, 2021 7.41%
Jun 30, 2021 23.48%
Mar 31, 2021 6.44%
Dec 31, 2020 -13.21%
Sep 30, 2020 5.50%
Jun 30, 2020 5.49%
Mar 31, 2020 1.15%
Dec 31, 2019 -3.43%
Sep 30, 2019 -2.93%
Jun 30, 2019 0.24%
Mar 31, 2019 2.93%
Dec 31, 2018 -17.68%
Sep 30, 2018 -0.34%
Jun 30, 2018 -3.35%
Mar 31, 2018 -1.93%
Dec 31, 2017 -10.21%
Sep 30, 2017 -3.05%
Jun 30, 2017 37,364.15%
Mar 31, 2017 -99.74%
Dec 31, 2016 -8.30%
Sep 30, 2016 39,500.90%
Jun 30, 2016 6.73%
Mar 31, 2016 -99.77%
Dec 31, 2015 -2.00%
Sep 30, 2015 -2.06%
Jun 30, 2015 -2.67%
Mar 31, 2015 -1.79%
Dec 31, 2014 7.56%
Sep 30, 2014 -6.51%
Jun 30, 2014 -7.70%
Mar 31, 2014 0.45%
Dec 31, 2013 4.64%
Sep 30, 2013 -0.20%
Jun 30, 2013 -9.89%
Mar 31, 2013 0.26%
Dec 31, 2012 -4.72%
Sep 30, 2012 0.93%
Jun 30, 2012 0.63%
Mar 31, 2012 0.65%
Dec 31, 2011 3.27%
Sep 30, 2011 -4.80%
Jun 30, 2011 1.91%
Mar 31, 2011 0.06%
Dec 31, 2010 -2.14%
Sep 30, 2010 0.68%
Jun 30, 2010 -4.44%
Mar 31, 2010 -1.87%
Dec 31, 2009 142.55%
Sep 30, 2009 11.49%